Sung Wan Kim
Sung Wan Kim ( August 21, 1940, Pusan, South Korea - February 24, 2020, Salt Lake City) was a Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry and Distinguished Professor of Bioengineering at the University of Utah. He is the Founder and Co-Director of the University of Utah's Center for Controlled Chemical Delivery (founded in 1986 under the auspices of the State of Utah's Centers of Excellence Program). Biography. Dr. Kim received his B.S. and M.S. at Seoul National University in 1963 and 1965, respectively. In 1969, he received his Ph.D. in Physical Chemistry at the University  of Utah under Professor Henry Eyring. Dr. Kim made considerable contributions to and was considered a pioneer in drug delivery. He was the founder of the International Symposium on Recent Advances in Drug Delivery, which is held biennially in Salt Lake City, Utah. He was an elected member of the United States National Academies' Institute of Medicine (1999) and the National Academy of Engineering (2003). He was a Fellow in the American Association of Pharmaceutical Scientists, Biomaterials Society and American Institute for Medical and Biological Engineering. Dr. Kim trained more than 100 scientists from 13 countries, had 25 U.S. Patents  and more than 550 publications. In addition to his contributions to academia, Dr. Kim was a successful entrepreneur. He was the founder of Expression Genetics, Inc., MacroMed, Inc. (Acquired by Protherics, Plc) and a co-founder of TheraTech, Inc. (Acquired by Watson Pharmaceuticals). A naturalized U.S. citizen, Dr. Kim was married and had two children. Awards. He was awarded the Outstanding Paper in the Journal of Controlled Release three times, in 1989, 1991, and 1998.